WebNov 2, 2024 · Corcept Therapeutics is battling to keep drug makers from manufacturing generics of its only commercially available drug while working to create new products. The company is facing a potential... WebNov 8, 2024 · Corcept is a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the hormone...
Corcept Therapeutics - Wikipedia
WebDec 7, 2024 · Based on its successful study , Corcept filed a New Drug Application (NDA) for Korlym, a 300 mg mifepristone tab-let. It sought approval for the administration of … WebGet Shruti Goel's email address (s*****@corcept.com) and phone number at RocketReach. Get 5 free searches. Rocketreach finds email, phone & social media for 450M+ professionals. Try for free at rocketreach.co butler freeport rails to trails map
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims …
WebAug 24, 2024 · Corcept entered into an agreement with Dohmen Life Sciences Services, LLC (“Dohmen”) in May of 2013 to provide this service. Id. at ¶ 115. Per the terms of the service agreement, Dohmen distributed Korlym to patients and recorded inventory levels. Id. at ¶ 116. Dohmen was also responsible for providing Corcept with a monthly itemized ... WebApr 4, 2024 · Corcept Therapeutics has an overall rating of 3.0 out of 5, based on over 23 reviews left anonymously by employees. 49% of employees would recommend working at Corcept Therapeutics to a friend and 64% have a positive outlook for the business. This rating has decreased by -14% over the last 12 months. WebDec 7, 2024 · Corcept conducted the drug-drug interaction study de-scribed in Lee, collecting data on co-administration of mif-epristone with a strong CYP3A inhibitor. Based on that data, Corcept sought and received the ’214 patent . The ’214 patent relates to methods of treating Cushing’s syndrome by co-administering mifepristone and a strong CYP3A in- cd covers ipod